BioXcel Therapeutics, Inc.

Historical 13F Holders

Symbol
BTAI
CUSIP
09075P105
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 09075P105 since 12/18/2024, newest first.

Filer % of Class Filed
Qatar Investment Authority 13G/A Amendment 1 0.6% 3/30/2026
Event 12/31/2025
Oaktree Capital Group Holdings GP, LLC 13G/A Amendment 1
2.7% 5/15/2025
Event 3/31/2025
Oaktree Capital Group Holdings GP, LLC 13G
5.2% 12/18/2024
Event 11/25/2024
Qatar Investment Authority 13G 5.2% 12/18/2024
Event 11/25/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q4 52 8.63 M $3.23M
2024 Q3 52 3.10 M $1.89M
2024 Q2 76 9.90 M $12.7M
2024 Q1 75 9.69 M $27.3M
2023 Q4 75 9.58 M $28.3M
2023 Q3 87 10.2 M $26.4M
2023 Q2 95 17.7 M $118M
2023 Q1 100 21.7 M $405M
2022 Q4 85 13.8 M $297M
2022 Q3 86 11.9 M $140M
2022 Q2 96 12.7 M $167M
2022 Q1 98 13.1 M $274M
2021 Q4 96 14.1 M $287M
2021 Q3 105 12.8 M $388M
2021 Q2 111 13.0 M $379M
2021 Q1 119 11.0 M $475M
2020 Q4 120 12.4 M $574M
2020 Q3 110 11.9 M $515M
2020 Q2 108 8.12 M $431M
2020 Q1 74 6.79 M $151M
2019 Q4 44 4.42 M $64.4M
2019 Q3 46 4.19 M $29.5M
2019 Q2 37 3.00 M $32.6M
2019 Q1 21 2.51 M $24.9M
2018 Q4 12 2.42 M $9.35M
2018 Q3 20 3.26 M $25.0M
2018 Q2 20 3.72 M $34.2M
2018 Q1 22 4.70 M $47.9M